Skip to main content

Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials

Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials

Bard Proposes Ventralight ST & Ventralex Claims For Initial Trials

Introduction

C.R. Bard and its Davol, Inc. subsidiary have proposed that from over a thousand lawsuits faced by them, claims related to Bard Ventralight ST and Bard Ventralex mesh be the first to go before a jury later this year.

The company faces more than 3,500 lawsuits with similar allegations from plaintiffs due to various hernia polypropylene mesh device, namely Ventralex, Ventralight, PerFix, 3DMax, and other devices. The outcomes of these trials will not be forced on other pending lawsuits. U.S. District Judge Edmund A. Sargus in the Southern District of Ohio will look into the proceedings of the trials which are scheduled to begin on May 11, 2020; July 13, 2020; and September 14, 2020.

Bard has proposed to start the trials with Ventralight ST and Ventralex, as the lawsuits involving these devices are more as compared to other devices, which will ease the process of determining the potential settlement.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

GSK CEO Strives to Resolve Zantac Litigation Drag on Shares

Categories: Zantac

GSK Plc’s CEO has made it a priority to ensure that the majority of the company’s employees remain focused on the company's core mission, rather than the ongoing…

J&J Files Third Bankruptcy to Resolve Talc Cancer Lawsuits

Categories: Talcum

In an effort to settle tens of thousands of ovarian cancer lawsuits linked to its talcum powder products, Johnson & Johnson has once again…

Baltimore to Sue Drug Distributors Over Opioid Crisis

Categories: Opioids

Baltimore is set to go to trial in its $11 billion lawsuit against drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of contributing to the…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!